Plunkett Research Online: Caladrius Biosciences Inc

CALADRIUS BIOSCIENCES INC (CLBS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Caladrius Biosciences Inc is a biopharmaceutical company. It develops novel proprietary cell therapy products. It is engaged in the preservation & enhancement of human health through the development of cell based therapeutics......



Caladrius Biosciences Inc
Ticker: CLBS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 212-584-4180
Fax: 646-514-7787
Address: 106 Allen Road
2nd Floor
Basking Ridge, NJ 07920 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Stem Cell Processing
Contract Research & Development
Drug Discovery & Development
ContactsDescription
Joseph TalamoCFO/Chief Accounting Officer/Senior VP
Gregory BrownChairman of the Board/Director
See More

Auditor: Grant Thornton LLP
Legal Advisor: Lowenstein Sandler PC
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
VSEL
Progenitor Cell Therapy LLC
Amorcyte LLC
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: